These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25055988)

  • 1. Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study.
    Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Albertsen IE; Lane DA; Lip GY; Larsen TB
    Thromb Haemost; 2014 Oct; 112(4):789-95. PubMed ID: 25055988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index and adverse events in patients with incident atrial fibrillation.
    Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Lip GY; Larsen TB
    Am J Med; 2013 Jul; 126(7):640.e9-17. PubMed ID: 23601271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study.
    Albertsen IE; Rasmussen LH; Lane DA; Overvad TF; Skjøth F; Overvad K; Lip GY; Larsen TB
    Chest; 2014 Mar; 145(3):559-66. PubMed ID: 24091709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol intake and prognosis of atrial fibrillation.
    Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Albertsen IE; Lane DA; Lip GY; Larsen TB
    Heart; 2013 Aug; 99(15):1093-9. PubMed ID: 23766449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.
    Overvad TF; Skjøth F; Lip GY; Lane DA; Albertsen IE; Rasmussen LH; Larsen TB
    Stroke; 2015 Aug; 46(8):2168-74. PubMed ID: 26152296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
    Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C
    Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.
    Larsen TB; Lip GY; Skjøth F; Due KM; Overvad K; Hvilsted Rasmussen L
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):335-42. PubMed ID: 22534406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
    Pallisgaard JL; Lindhardt TB; Hansen ML; Schjerning AM; Olesen JB; Staerk L; Torp-Pedersen C; Gislason GH
    PLoS One; 2015; 10(10):e0141377. PubMed ID: 26513589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study.
    Fangel MV; Nielsen PB; Larsen TB; Christensen B; Overvad TF; Lip GYH; Goldhaber SZ; Jensen MB
    Int J Cardiol; 2018 Oct; 268():137-142. PubMed ID: 30041778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.
    Fang MC; Singer DE; Chang Y; Hylek EM; Henault LE; Jensvold NG; Go AS
    Circulation; 2005 Sep; 112(12):1687-91. PubMed ID: 16157766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.
    Hansen ML; Jepsen RM; Olesen JB; Ruwald MH; Karasoy D; Gislason GH; Hansen J; Køber L; Husted S; Torp-Pedersen C
    Europace; 2015 Jan; 17(1):18-23. PubMed ID: 25231909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in risk of stroke in patients with a hospital diagnosis of nonvalvular atrial fibrillation: National Cohort Study in Denmark, 1980-2002.
    Frost L; Vukelic Andersen L; Vestergaard P; Husted S; Mortensen LS
    Neuroepidemiology; 2006; 26(4):212-9. PubMed ID: 16645320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L
    Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
    J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and bleeding in atrial fibrillation with chronic kidney disease.
    Olesen JB; Lip GY; Kamper AL; Hommel K; Køber L; Lane DA; Lindhardsen J; Gislason GH; Torp-Pedersen C
    N Engl J Med; 2012 Aug; 367(7):625-35. PubMed ID: 22894575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
    Hijazi Z; Siegbahn A; Andersson U; Granger CB; Alexander JH; Atar D; Gersh BJ; Mohan P; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L;
    Circulation; 2014 Feb; 129(6):625-34. PubMed ID: 24226808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.